Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.
van Luin
Matthijs
M
Brouwer
Anne-Marie
AM
van der Ven
Andre
A
de Lange
Wiel
W
van Schaik
Ron H N
RH
Burger
David M
DM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D048588:Benzoxazines / Q000009:adverse effects*; D003521:Cyclopropanes; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000480:Alkynes; D019380:Anti-HIV Agents; D000904:Antibiotics, Antitubercular; D048588:Benzoxazines; D003521:Cyclopropanes; C098320:efavirenz; D012293:Rifampin